Erik Max Wulff

Erik Max Wulff is a seasoned professional in the field of pharmacology with extensive experience in drug discovery and development, particularly in obesity and diabetes. Currently serving as Senior Director and Head of Translational Pharmacology at Zealand Pharma since January 2023, Erik previously held roles at Gubra, where responsibilities included managing tissue research and pharmacology groups and contributing to pre-clinical contract research activities. Erik's tenure at Novo Nordisk spanned nearly two decades, culminating in directorial roles involving the management of multiple departments focused on early drug discovery. Erik's academic credentials include a DVM from the University of Copenhagen and an MMPI Diploma from Copenhagen Business School, complemented by ongoing education in Life Science Intrapreneurship with PWC.